Americans tend to support the US government's involvement in world affairs, but there is an increasingly large partisan divide on the country's approach to global healthcare.
The partisan divide regarding the US government’s approach to global healthcare has increased, according to a new survey from the Kaiser Family Foundation.
As a whole, Americans tend to support US involvement in world affairs, with 65% in favor of the nation taking a major global role. Opinions vary, however, on extent to which the US should be involved and how, especially in terms of healthcare.
More than half (53%) of Americans believe that the US is doing enough to aid developing countries with their health, while 46% believe that the US is committing more than its “fair share” of aid. The majority of Republicans and independents (68% and 59%, respectively) say that the US is committing enough aid to developing countries’ health; the majority of Democrats, at 52%, say that the US is not doing enough.
The difference in party opinions also extends to its leadership. Hart Research Associates and Public Opinion strategies polled various global health leaders and foreign policy leaders on their opinions of the US government’s involvement. They found that left-leaning leaders favored greater integration across initiatives and more organization among key stakeholders, stating that the US should be more active as a facilitator, organizer, and coordinator. However, right-leaning leaders did not focus on integration so much as advocating for cooperation among current and potential players.
In terms of estimating US spending on global health, 34% of Americans said the US was spending the right amount, 30% said the US was spending too much, and 26% said the US was spending too little. The parties split in a similar fashion, with more Republicans saying the US was spending too much and Democrats saying that the US was spending too little. (Independents were equally divided on this issue.)
Regardless of what amount Americans said the government was spending on global health, roughly 70% considered US spending as ineffective and that the “number of lives saved relative to the amount of money spent” did not balance out. More than half (55%) said that spending more money would not lead to meaningful progress. Americans quoted various problems that they thought negatively impacted the usage of US aid, with corruption and misuse of funds named the top 2 issues. Larger numbers of Republicans than Democrats believed that meaningful progress would not be achieved with more spending.
As it turns out, Americans tend to overestimate how much the government spends on foreign aid. Americans believe that the US spends an average of 31% of the federal budget on foreign aid; only 3% of Americans correctly stated that the US spends 1% or less.
Americans were also divided on the reasons why the US government should help with global health issues. Only 9% said that it would improve the US image worldwide; 11% said it would create new markets for the US economy; 14% said it would protect nationwide health by preventing the spread of international disease; and another 14% said it would bolster diplomatic relations. However, most (46%), said that it was just the right thing to do.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More